EP 1189625 A1 20020327 - PHARMACEUTICAL PREPARATION CONTAINING MODIFICATIONS OF SURFACTANT PROTEIN B (SP-B) AND SURFACTANT PROTEIN C (SP-C)
Title (en)
PHARMACEUTICAL PREPARATION CONTAINING MODIFICATIONS OF SURFACTANT PROTEIN B (SP-B) AND SURFACTANT PROTEIN C (SP-C)
Title (de)
PHARMAZEUTISCHE ZUBEREITUNG ENTHALTEND MODIFIKATIONEN VON SURFACTANT PROTEIN B (SP-B) UND SURFACTANT PROTEIN C (SP-C)
Title (fr)
PREPARATION PHARMACEUTIQUE CONTENANT DES MODIFICATIONS DE LA PROTEINE B DU SURFACTANT (SP-B) ET DE LA PROTEINE C DU SURFACTANT (SP-C)
Publication
Application
Priority
- EP 00938727 A 20000602
- EP 0005032 W 20000602
- EP 99111385 A 19990611
Abstract (en)
[origin: WO0076535A1] The invention describes a novel pharmaceutical preparation for treating IRDS or ALI, comprising at least one modification of surfactant protein B (SP-B) and at least one modification of surfactant protein C (SP-C).
IPC 1-7
IPC 8 full level
A61K 47/02 (2006.01); A61K 31/20 (2006.01); A61K 31/683 (2006.01); A61K 31/685 (2006.01); A61K 38/00 (2006.01); A61K 38/17 (2006.01); A61P 11/00 (2006.01); C07K 14/785 (2006.01)
CPC (source: EP)
A61K 9/0082 (2013.01); A61K 38/1709 (2013.01); A61P 11/00 (2017.12); C07K 14/785 (2013.01)
Citation (search report)
See references of WO 0076535A1
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0076535 A1 20001221; AU 5400000 A 20010102; CA 2372558 A1 20001221; EP 1189625 A1 20020327; JP 2003501481 A 20030114
DOCDB simple family (application)
EP 0005032 W 20000602; AU 5400000 A 20000602; CA 2372558 A 20000602; EP 00938727 A 20000602; JP 2001502868 A 20000602